Download PDF
Thromb Haemost 1985; 54(04): 897
DOI: 10.1055/s-0038-1660159
Letter to the Editor
Schattauer GmbH Stuttgart

The Prevalence of HTLV-III and HTLV-I Antibodies in Serum of Hemophiliacs

A De Rossi
University of Padua, Medical School, Department of Oncology and II Chair of Medicine, Padua, Italy
,
O Dalla Gassa
University of Padua, Medical School, Department of Oncology and II Chair of Medicine, Padua, Italy
,
L Chieco Bianchi
University of Padua, Medical School, Department of Oncology and II Chair of Medicine, Padua, Italy
,
R Dal Bo Zanon
University of Padua, Medical School, Department of Oncology and II Chair of Medicine, Padua, Italy
,
M Boscaro
University of Padua, Medical School, Department of Oncology and II Chair of Medicine, Padua, Italy
,
A Girolami
University of Padua, Medical School, Department of Oncology and II Chair of Medicine, Padua, Italy
› Author Affiliations
Further Information

Publication History

Received 30 July 1985

Accepted 30 July 1985

Publication Date:
19 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Chorba TL, Jason JM, Ramsey RB, Lechner K, Pabinger-Fasching I, Kalyanaraman VS, McDougal JS, Cabradilla CD, Tregillus LC, Lawrence DN, Evatt BL. HTLV-I antibody status in haemophilia patients treated with factor concentrates prepared from US plasma sources and in hemophilia patients with AIDS. Thromb Haemostas 1985; 53: 180-182
    PubMedGoogle Scholar
  • 2 Girolami A, Molaro G, Lazzarin M, Scarpa R, Brunetti A. A new congenital hemorrhagiccondition due to the presence ofan abnormal Factor X (Factor X Friuli). A study of a large kindred. Br J Haematol 1970; 19: 179-192
    CrossrefPubMedGoogle Scholar